Franklin Resources Inc. Has $6.67 Million Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Franklin Resources Inc. boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 273.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 105,228 shares of the company’s stock after purchasing an additional 77,027 shares during the period. Franklin Resources Inc. owned about 0.11% of Acadia Healthcare worth $6,673,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of ACHC. State Street Corp raised its stake in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after acquiring an additional 95,613 shares during the period. Principal Financial Group Inc. increased its position in Acadia Healthcare by 19.4% during the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after buying an additional 104,359 shares during the period. LMR Partners LLP acquired a new stake in shares of Acadia Healthcare during the third quarter worth $1,616,000. Texas Permanent School Fund Corp boosted its position in shares of Acadia Healthcare by 11.3% in the second quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock valued at $6,067,000 after acquiring an additional 9,115 shares during the period. Finally, Sivik Global Healthcare LLC grew its stake in shares of Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock valued at $7,292,000 after acquiring an additional 34,997 shares in the last quarter.

Acadia Healthcare Stock Down 1.8 %

Shares of NASDAQ:ACHC opened at $37.90 on Monday. Acadia Healthcare Company, Inc. has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a market capitalization of $3.52 billion, a PE ratio of 12.43, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a fifty day moving average of $43.80 and a 200-day moving average of $60.81.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have issued reports on ACHC. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada cut their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Finally, KeyCorp started coverage on Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.